GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
Eli Lilly, the pharmaceutical giant, filed a sweeping set of lawsuits in federal court, accusing four telehealth startups—Mochi Health, Fella Health, Empower Pharmacy, and Henry Meds—of illegally selling off-brand, compounded versions of its blockbuster weight-loss and diabetes drugs, Zepbound and Mounjaro.
